Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: ToRsemide for pOstpartum HYpertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ToRsemide in postpartum hypertension associated with preeclampsia; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Torsemide (torsemide)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Preeclampsia | Phase 2 | Status: COMPLETED | Results posted: 2019-04-10